These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15119047)

  • 41. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The first monoclonal antibody against IgE. The end of allergies? (interview by Dr. Judith Neumaier)].
    Bergmann KC
    MMW Fortschr Med; 2002 Sep; 144(35-36):12. PubMed ID: 12380350
    [No Abstract]   [Full Text] [Related]  

  • 43. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Grazax for hay fever?
    BMJ Group
    Drug Ther Bull; 2008 Feb; 46(2):9-10. PubMed ID: 18256175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?
    Jacobsen L; Valovirta E
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):556-60. PubMed ID: 17989534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care.
    Röder E; Berger MY; Hop WC; Bernsen RM; de Groot H; Gerth van Wijk R
    J Allergy Clin Immunol; 2007 Apr; 119(4):892-8. PubMed ID: 17321581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introduction: anti-IgE.
    Bochner B; Saini S
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):1-2. PubMed ID: 16222079
    [No Abstract]   [Full Text] [Related]  

  • 49. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial.
    Röder E; Berger MY; de Groot H; Gerth van Wijk R
    Clin Exp Allergy; 2008 Oct; 38(10):1659-67. PubMed ID: 18631346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S; Richter D; Cepelak I; Benko B
    Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is interstitial cystitis an allergic disorder?: A case of interstitial cystitis treated successfully with anti-IgE.
    Lee J; Doggweiler-Wiygul R; Kim S; Hill BD; Yoo TJ
    Int J Urol; 2006 May; 13(5):631-4. PubMed ID: 16771742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of pollens in allergy.
    Freye HB
    Med Health R I; 2008 Jun; 91(6):174-5. PubMed ID: 18610805
    [No Abstract]   [Full Text] [Related]  

  • 56. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
    Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
    J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Injection of anti-IgE antibodies will suppress IgE and allergic symptoms.
    Patalano F
    Allergy; 1999 Feb; 54(2):103-10. PubMed ID: 10221432
    [No Abstract]   [Full Text] [Related]  

  • 58. [Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)].
    Beeh KM; Beier J; Buhl R
    Pneumologie; 2004 Aug; 58(8):546-51. PubMed ID: 15293167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The type of sensitizing allergen can affect the evolution of respiratory allergy.
    Marogna M; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
    Allergy; 2006 Oct; 61(10):1209-15. PubMed ID: 16942571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.